UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Standard Versus Intensified Chemotherapy With Granulocyte Colony-Stimulating Factor Support in Small-Cell Lung Cancer: A Prospective European Organization for Research and Treatment of Cancer–Lung Cancer Group Phase III Trial—08923

Journal of clinical oncology, 2002-10, Vol.20 (19), p.3947-3955

2002

Volltextzugriff (PDF)

European Organization for Research and Treatment of Cancer (EORTC) 08957 Phase II Study of Topotecan in Combination with Cisplatin as Second-Line Treatment of Refractory and Sensitive Small Cell Lung Cancer

Clinical cancer research, 2003-01, Vol.9 (1), p.143-150

2003

Volltextzugriff (PDF)

Predictive and prognostic value of early response assessment using 18FDG-PET in advanced non-small cell lung cancer patients treated with erlotinib

Cancer chemotherapy and pharmacology, 2014-02, Vol.73 (2), p.299-307

2014

Volltextzugriff (PDF)

Hypertriglyceridaemia with bexarotene in cutaneous T cell lymphoma: the role of omega‐3 fatty acids

British journal of haematology, 2009-04, Vol.145 (1), p.84-86

2009

Volltextzugriff (PDF)

Epidermal growth factor receptor targeted therapy by ZD 1839 (Iressa) in patients with brain metastases from non-small cell lung cancer (NSCLC)

Lung cancer (Amsterdam, Netherlands), 2003-08, Vol.41 (2), p.227-231

2003

Volltextzugriff (PDF)

A phase II study of paclitaxel in advanced bronchioloalveolar carcinoma (EORTC trial 08956)

Lung cancer (Amsterdam, Netherlands), 2005-10, Vol.50 (1), p.91-96

2005

Volltextzugriff (PDF)

Detection of follicular fluid and serum antibodies by protein microarrays in women undergoing in vitro fertilization treatment

Journal of reproductive immunology, 2011-04, Vol.89 (1), p.62-69

2011

Volltextzugriff (PDF)

Cisplatin and etoposide combination chemotherapy for locally advanced or metastatic thymoma. A phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group

Journal of clinical oncology, 1996-03, Vol.14 (3), p.814-820

1996

Volltextzugriff (PDF)

Palliative and therapeutic activity of IL-2 immunotherapy in unresectable malignant pleural mesothelioma with pleural effusion: Results of a phase II study on 31 consecutive patients

Lung cancer (Amsterdam, Netherlands), 2001-02, Vol.31 (2-3), p.303-310

2001

Volltextzugriff (PDF)

Mismatch repair system (MMR) status correlates with response and survival in non-small cell lung cancer (NSCLC) patients

Lung cancer (Amsterdam, Netherlands), 2006-07, Vol.53 (1), p.103-109

2006

Volltextzugriff (PDF)

Study of pretreatment serum levels of HER‐2/neu oncoprotein as a prognostic and predictive factor in patients with advanced nonsmall cell lung carcinoma

Cancer, 2001-10, Vol.92 (7), p.1896-1904

2001

Volltextzugriff (PDF)

Phase II study of taxol combined with ifosfamide and carboplatin in the treatment of stage IIIb-IV non-small-cell lung cancer

American journal of clinical oncology, 2003-02, Vol.26 (1), p.84-88

2003

Volltextzugriff (PDF)

Biologic and clinical effects of continuous infusion interleukin‐2 in patients with non‐small cell lung cancer

Cancer, 1994-03, Vol.73 (5), p.1353-1360

1994

Volltextzugriff (PDF)

Erythropoietin and granulocyte-macrophage colony-stimulating factor allow acceleration and dose escalation of cyclophosphamide/epidoxorubicin/5-fluorouracil chemotherapy : a dose-finding study in patients with advanced breast cancer

Cancer chemotherapy and pharmacology, 1996, Vol.38 (6), p.487-494

1996

Volltextzugriff (PDF)

Thymidine labelling index as prognostic factor in resected non-small cell lung cancer

European journal of cancer & clinical oncology, 1990, Vol.26 (5), p.622-625

1990

Volltextzugriff (PDF)

Hypercoagulable state induced by cytostatic drugs in stage ii breast cancer patients

Cancer, 1986-09, Vol.58 (5), p.1032-1036

1986

Volltextzugriff (PDF)

Randomized comparison of two chemotherapy, radiotherapy schemes for stage iii and iv unresectable squamous cell carcinoma of the head and neck

The Laryngoscope, 1990-05, Vol.100 (5), p.531-535

1990

Volltextzugriff (PDF)

A phase II study with danazol in metastatic breast cancer

American journal of clinical oncology, 1987-10, Vol.10 (5), p.407-409

1987

Volltextzugriff (PDF)

1 – 18 von 18

Suche als RSS-Feed

Aktive Filter

ThemaTumors

ThemaBiological And Medical Sciences

ThemaFemale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(18)
Mit Volltextzugriff
(18)

Publikationsform

Artikel
(18)

Sprache

Englisch
(18)

Erscheinungsjahr

n.n

Thema

Humans
(18)
Medical Sciences
(17)
Adult
(16)
Middle Aged
(16)
Aged
(15)
Life Sciences & Biomedicine
(14)
Male
(14)
Science & Technology
(14)
Oncology
(12)
Pharmacology. Drug Treatments
(12)
Antineoplastic Agents
(10)
Chemotherapy
(8)
Lung Neoplasms - Drug Therapy
(8)
Lung Neoplasms - Pathology
(7)
Treatment Outcome
(7)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(6)
Neoplasm Staging
(6)
Pneumology
(6)

13 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Standard Versus Intensified Chemotherapy With Granulocyte Colony-Stimulating Factor Support in Small-Cell Lung Cancer: A Prospective European Organization for Research and Treatment of Cancer–Lung Cancer Group Phase III Trial—08923

European Organization for Research and Treatment of Cancer (EORTC) 08957 Phase II Study of Topotecan in Combination with Cisplatin as Second-Line Treatment of Refractory and Sensitive Small Cell Lung Cancer

Predictive and prognostic value of early response assessment using 18FDG-PET in advanced non-small cell lung cancer patients treated with erlotinib

Hypertriglyceridaemia with bexarotene in cutaneous T cell lymphoma: the role of omega‐3 fatty acids

Epidermal growth factor receptor targeted therapy by ZD 1839 (Iressa) in patients with brain metastases from non-small cell lung cancer (NSCLC)

A phase II study of paclitaxel in advanced bronchioloalveolar carcinoma (EORTC trial 08956)

Detection of follicular fluid and serum antibodies by protein microarrays in women undergoing in vitro fertilization treatment

Cisplatin and etoposide combination chemotherapy for locally advanced or metastatic thymoma. A phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group

Palliative and therapeutic activity of IL-2 immunotherapy in unresectable malignant pleural mesothelioma with pleural effusion: Results of a phase II study on 31 consecutive patients

Mismatch repair system (MMR) status correlates with response and survival in non-small cell lung cancer (NSCLC) patients

Study of pretreatment serum levels of HER‐2/neu oncoprotein as a prognostic and predictive factor in patients with advanced nonsmall cell lung carcinoma

Phase II study of taxol combined with ifosfamide and carboplatin in the treatment of stage IIIb-IV non-small-cell lung cancer

Biologic and clinical effects of continuous infusion interleukin‐2 in patients with non‐small cell lung cancer

Erythropoietin and granulocyte-macrophage colony-stimulating factor allow acceleration and dose escalation of cyclophosphamide/epidoxorubicin/5-fluorouracil chemotherapy : a dose-finding study in patients with advanced breast cancer

Thymidine labelling index as prognostic factor in resected non-small cell lung cancer

Hypercoagulable state induced by cytostatic drugs in stage ii breast cancer patients

Randomized comparison of two chemotherapy, radiotherapy schemes for stage iii and iv unresectable squamous cell carcinoma of the head and neck

A phase II study with danazol in metastatic breast cancer

Aktive Filter

Suchergebnisse filtern